Nesiritide acetate

Min.Order / FOB Price:Get Latest Price

0 Metric Ton	Negotiable

0 Metric Ton

Negotiable

Min.Order :0 Metric Ton
Purity: Greater than 95.0%
Payment Terms : L/C,T/T,Other

Keywords

Nesiritide most affordable price CAS# 114471-18-0

Quick Details

Appearance:
Application:
PackAge:according to customer's requirements
ProductionCapacity:2|Kilogram|Month
Storage:
Transportation:by air

Superiority:

Professional peptide manufacturer in China.

high quality with GMP grade

large scale with Competitive price

Our products include: Generic bulk peptide APIs, Cosmetic peptide, custom peptides and veterinary peptides.

Nesiritide acetate

CAS# 114471-18-0

Details:

Company Profile:

company name:Shenzhen JYMed Technology Co.,Ltd.

Year Established:2009

Capital: 89.5 Million RMB

Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin

Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,.....

We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.JYM has successfully submitted a lot

of ANDA peptide APIs and formulated products with CFDA and have over fourty patents approved.

Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.

With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.

View All